Literature DB >> 9358209

Individualization of theophylline infusion rate on the basis of a nonlinear compartmental pharmacokinetic model.

G C Nikiforidis1, C P Argyropoulos, T I Kassimatis, D S Ithakissios.   

Abstract

In the present paper, a nonlinear compartmental model for theophylline pharmacokinetics is developed. The analytical solution of the model, in parametric form, is derived under plateau conditions for plasma metabolite concentration. The parameters are obtained from plasma and urine data using best fitting techniques and their values are used in order to calculate maintenance intravenous infusion. Numerical simulation is then performed in order to compare the drug concentration obtained by our approach with that of alternative intravenous regimens. The differences argue for individualized dosage regimens, since theophylline is a drug with a narrow therapeutic window and its concentration at the active sites strongly depends on characteristic parameters of the patient's response. Our results show that it is possible to estimate the patients' parameters during the first 8 h after intravenous administration of the drug and these parameters can be used to design an individualized dosage regimen in patients receiving theophylline intravenously.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358209     DOI: 10.1007/BF03189817

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  23 in total

Review 1.  Nonlinear pharmacokinetics: clinical Implications.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

2.  Distribution and elimination of digoxin in infants.

Authors:  G Wettrell
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

4.  Quantitative pooling of Michaelis-Menten equations in models with parallel metabolite formation paths.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

5.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

6.  Problems associated with analysis of pharmacokinetic models.

Authors:  W J Westlake
Journal:  J Pharm Sci       Date:  1971-06       Impact factor: 3.534

7.  Nonlinear theophylline elimination.

Authors:  D D Tang-Liu; R L Williams; S Riegelman
Journal:  Clin Pharmacol Ther       Date:  1982-03       Impact factor: 6.875

8.  Pharmacokinetic analysis of the disposition of intravenous theophylline in young children.

Authors:  P M Loughnan; D S Sitar; R I Ogilvie; A Eisen; Z Fox; A H Neims
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

9.  A new simplified assay for the quantitation of theophylline and its major metabolites in urine by high-performance liquid chromatography.

Authors:  M B Kester; C L Saccar; M L Rocci; H C Mansmann
Journal:  J Pharm Sci       Date:  1987-03       Impact factor: 3.534

10.  Capturing clinical expertise. A computer program that considers clinical responses to digitalis.

Authors:  G A Gorry; H Silverman; S G Pauker
Journal:  Am J Med       Date:  1978-03       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.